vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and PURE CYCLE CORP (PCYO). Click either name above to swap in a different company.

Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $9.1M, roughly 1.0× PURE CYCLE CORP). PURE CYCLE CORP runs the higher net margin — 50.0% vs -234.3%, a 284.3% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 58.8%). Over the past eight quarters, PURE CYCLE CORP's revenue compounded faster (69.0% CAGR vs 35.3%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

Pure Cycles, is a bicycle company based in Los Angeles, California that was founded by Michael Fishman, Jordan Schau, Zachary Schau and Austin Stoffers in 2010, as Pure Fix Cycles.

FHTX vs PCYO — Head-to-Head

Bigger by revenue
FHTX
FHTX
1.0× larger
FHTX
$9.2M
$9.1M
PCYO
Growing faster (revenue YoY)
FHTX
FHTX
+165.0% gap
FHTX
223.8%
58.8%
PCYO
Higher net margin
PCYO
PCYO
284.3% more per $
PCYO
50.0%
-234.3%
FHTX
Faster 2-yr revenue CAGR
PCYO
PCYO
Annualised
PCYO
69.0%
35.3%
FHTX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FHTX
FHTX
PCYO
PCYO
Revenue
$9.2M
$9.1M
Net Profit
$-21.7M
$4.6M
Gross Margin
68.4%
Operating Margin
-258.2%
48.0%
Net Margin
-234.3%
50.0%
Revenue YoY
223.8%
58.8%
Net Profit YoY
-11.1%
16.0%
EPS (diluted)
$-0.35
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
PCYO
PCYO
Q4 25
$9.2M
$9.1M
Q3 25
$8.2M
$11.2M
Q2 25
$7.6M
$5.1M
Q1 25
$6.0M
$4.0M
Q4 24
$2.9M
$5.8M
Q3 24
$7.8M
$12.6M
Q2 24
$6.9M
$7.6M
Q1 24
$5.0M
$3.2M
Net Profit
FHTX
FHTX
PCYO
PCYO
Q4 25
$-21.7M
$4.6M
Q3 25
$-15.8M
$6.1M
Q2 25
$-17.9M
$2.3M
Q1 25
$-18.8M
$809.0K
Q4 24
$-19.5M
$3.9M
Q3 24
$-19.1M
$6.6M
Q2 24
$-23.0M
$2.8M
Q1 24
$-25.0M
$118.0K
Gross Margin
FHTX
FHTX
PCYO
PCYO
Q4 25
68.4%
Q3 25
67.7%
Q2 25
63.4%
Q1 25
38.2%
Q4 24
63.8%
Q3 24
77.8%
Q2 24
64.0%
Q1 24
55.6%
Operating Margin
FHTX
FHTX
PCYO
PCYO
Q4 25
-258.2%
48.0%
Q3 25
-226.9%
53.1%
Q2 25
-279.2%
26.0%
Q1 25
-385.0%
-33.2%
Q4 24
-840.5%
29.9%
Q3 24
-305.5%
62.0%
Q2 24
-386.6%
40.3%
Q1 24
-558.3%
-11.5%
Net Margin
FHTX
FHTX
PCYO
PCYO
Q4 25
-234.3%
50.0%
Q3 25
-194.4%
54.5%
Q2 25
-237.3%
43.9%
Q1 25
-316.4%
20.3%
Q4 24
-682.9%
68.4%
Q3 24
-244.9%
52.6%
Q2 24
-333.6%
37.2%
Q1 24
-495.4%
3.7%
EPS (diluted)
FHTX
FHTX
PCYO
PCYO
Q4 25
$-0.35
$0.19
Q3 25
$-0.25
$0.26
Q2 25
$-0.28
$0.09
Q1 25
$-0.30
$0.03
Q4 24
$-0.23
$0.16
Q3 24
$-0.31
$0.27
Q2 24
$-0.45
$0.12
Q1 24
$-0.59
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
PCYO
PCYO
Cash + ST InvestmentsLiquidity on hand
$80.9M
$17.1M
Total DebtLower is stronger
$8.0M
Stockholders' EquityBook value
$-108.5M
$147.5M
Total Assets
$198.1M
$168.1M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
PCYO
PCYO
Q4 25
$80.9M
$17.1M
Q3 25
$89.3M
$21.9M
Q2 25
$72.6M
$14.4M
Q1 25
$61.0M
$16.5M
Q4 24
$55.5M
$19.0M
Q3 24
$57.7M
$22.1M
Q2 24
$138.9M
$20.5M
Q1 24
$79.3M
$20.6M
Total Debt
FHTX
FHTX
PCYO
PCYO
Q4 25
$8.0M
Q3 25
$6.8M
Q2 25
$6.9M
Q1 25
$6.9M
Q4 24
$6.9M
Q3 24
$6.9M
Q2 24
Q1 24
Stockholders' Equity
FHTX
FHTX
PCYO
PCYO
Q4 25
$-108.5M
$147.5M
Q3 25
$-89.7M
$142.7M
Q2 25
$-76.7M
$136.7M
Q1 25
$-61.7M
$134.4M
Q4 24
$-45.5M
$133.6M
Q3 24
$-28.3M
$129.7M
Q2 24
$-14.3M
$123.2M
Q1 24
$-97.5M
$120.4M
Total Assets
FHTX
FHTX
PCYO
PCYO
Q4 25
$198.1M
$168.1M
Q3 25
$205.0M
$162.3M
Q2 25
$226.2M
$151.7M
Q1 25
$258.7M
$149.7M
Q4 24
$284.0M
$149.7M
Q3 24
$308.4M
$147.4M
Q2 24
$328.6M
$140.4M
Q1 24
$255.0M
$135.2M
Debt / Equity
FHTX
FHTX
PCYO
PCYO
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
PCYO
PCYO
Operating Cash FlowLast quarter
$-22.3M
$-979.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.21×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
PCYO
PCYO
Q4 25
$-22.3M
$-979.0K
Q3 25
$-18.9M
$9.4M
Q2 25
$-21.0M
$-503.0K
Q1 25
$-24.0M
$-1.4M
Q4 24
$-24.5M
$5.7M
Q3 24
$-21.0M
$3.1M
Q2 24
$-25.5M
$892.0K
Q1 24
$-29.3M
$-457.0K
Free Cash Flow
FHTX
FHTX
PCYO
PCYO
Q4 25
Q3 25
Q2 25
$-21.0M
Q1 25
$-24.0M
Q4 24
$-25.0M
Q3 24
$-21.3M
Q2 24
$-25.6M
Q1 24
$-29.4M
FCF Margin
FHTX
FHTX
PCYO
PCYO
Q4 25
Q3 25
Q2 25
-278.2%
Q1 25
-403.2%
Q4 24
-875.3%
Q3 24
-273.0%
Q2 24
-371.0%
Q1 24
-583.1%
Capex Intensity
FHTX
FHTX
PCYO
PCYO
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.3%
Q1 25
0.5%
Q4 24
16.8%
Q3 24
4.0%
Q2 24
0.2%
Q1 24
2.0%
Cash Conversion
FHTX
FHTX
PCYO
PCYO
Q4 25
-0.21×
Q3 25
1.53×
Q2 25
-0.22×
Q1 25
-1.70×
Q4 24
1.44×
Q3 24
0.47×
Q2 24
0.32×
Q1 24
-3.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FHTX
FHTX

Segment breakdown not available.

PCYO
PCYO

Construction$6.5M71%
Water And Wastewater Resource Development Segment$2.5M27%

Related Comparisons